What Is A Breast Self Exam? Are Breast Self Exams Useful?

While breast self-exams are not recommended as a substitute for breast screening, most experts encourage women to become familiar with the way their breasts look and feel. This familiarity makes it much more likely that any changes might be detected early on…

In Post-’Mad Men’ World, Smoking Is Blue Collar Habit (CME/CE)

(MedPage Today) — Workers in blue- and pink-collar jobs are far more likely to smoke cigarettes than those in white-collar occupations, CDC researchers said.

CMS to Decide on Paying for New Valve Procedure

WASHINGTON (MedPage Today) — Responding to requests from two major cardiology groups, the Centers for Medicare and Medicaid Services has started the process of determining whether it will pay for transcatheter aortic valve replacement (TAVR) to treat aortic stenosis.

FDA Okays First Face Mask for Kids

WASHINGTON (MedPage Today) — The FDA has cleared the first single-use face mask for preventing the spread of airborne pathogens that is made especially for children.

Drugmaker Pulls Plug on Oral Anticoagulant

(MedPage Today) — Astellas Pharma has announced it is shutting down global development of darexaban maleate, a direct factor Xa inhibitor, after an acute coronary syndrome study revealed a higher bleeding risk associated with the drug.

FDA Okays First Face Mask for Kids

WASHINGTON (MedPage Today) — The FDA has cleared the first single-use face mask for preventing the spread of airborne pathogens that is made especially for children.

Roche inaugurates new clinical supply manufacturing facility in Nutley, N.J.

Roche announced today the opening of a new state-of-the-art clinical supply manufacturing facility on its campus in Nutley, N.J. The Roche Center of Excellence produces dosage forms of highly potent compounds for preclinical safety studies, and Phase 1 and 2 clinical studies.

Cincinnati Children’s to conduct first medication clinical trial for pediatric migraine

Cincinnati Children’s Hospital Medical Center has received a $12 million grant from the National Institutes of Health to conduct the first clinical trial to determine the medication of choice for preventing migraines in children and teens.

Array announces results from selumetinib Phase 2 combination study on KRAS-mutant NSCLC

Array BioPharma Inc. today announced results from a randomized Phase 2 placebo-controlled study conducted by AstraZeneca comparing the efficacy of selumetinib in combination with docetaxel with docetaxel alone in the second-line treatment of 87 patients prospectively selected with KRAS-mutant, locally advanced or metastatic non-small cell lung cancer.

Small Phase I trial shows HIV vaccine candidate is most powerful to date

Researchers at the Spanish Superior Scientific Research Council (CSIC) have successfully completed a small Phase I human clinical trial of an HIV vaccine candidate that granted 90 percent of 30 study participants an immunological response against the virus, Gizmag reports.